PAPER Furukawa A, Kawamoto Y, Chiba Y, Takei S, Hasegawa-Ishii S, Kawamura N, Yoshikawa K, Hosokawa M, Oikawa S, Kato M, Shimada A
SEARCH RESULTS
329960 RESULTS
PAPER Chen KD, Chang PT, Ping YH, Lee HC, Yeh CW, Wang PN
Gene expression profiling of peripheral blood leukocytes identifies and validates ABCB1 as a novel biomarker for Alzheimer's disease.
Neurobiol Dis. 2011 Sep;43(3):698-705. PubMed: 21669286PAPER Balazs R, Vernon J, Hardy J
Epigenetic mechanisms in Alzheimer's disease: progress but much to do.
Neurobiol Aging. 2011 Jul;32(7):1181-7. PubMed: 21669333PAPER Samadi A, Chioua M, Bolea I, de los Ríos C, Iriepa I, Moraleda I, Bastida A, Esteban G, Unzeta M, Gálvez E, Marco-Contelles J
Synthesis, biological assessment and molecular modeling of new multipotent MAO and cholinesterase inhibitors as potential drugs for the treatment of Alzheimer's disease.
Eur J Med Chem. 2011 Sep;46(9):4665-8. PubMed: 21669479PAPER Zhou X, Hu X, He W, Tang X, Shi Q, Zhang Z, Yan R
Interaction between amyloid precursor protein and Nogo receptors regulates amyloid deposition.
FASEB J. 2011 Sep;25(9):3146-56. PubMed: 21670066PAPER Ojha J, Masilamoni G, Dunlap D, Udoff RA, Cashikar AG
Sequestration of toxic oligomers by HspB1 as a cytoprotective mechanism.
Mol Cell Biol. 2011 Aug;31(15):3146-57. PubMed: 21670152PAPER Ahmed MA, Darwish ES, Khedr EM, El Serogy YM, Ali AM
Effects of low versus high frequencies of repetitive transcranial magnetic stimulation on cognitive function and cortical excitability in Alzheimer's dementia.
J Neurol. 2012 Jan;259(1):83-92. PubMed: 21671144PAPER Qureshi IA, Mehler MF
Advances in epigenetics and epigenomics for neurodegenerative diseases.
Curr Neurol Neurosci Rep. 2011 Oct;11(5):464-73. PubMed: 21671162PAPER Harashima S, Wang Y, Horiuchi T, Seino Y, Inagaki N
Purkinje cell protein 4 positively regulates neurite outgrowth and neurotransmitter release.
J Neurosci Res. 2011 Oct;89(10):1519-30. PubMed: 21671256PAPER Ladiwala AR, Mora-Pale M, Lin JC, Bale SS, Fishman ZS, Dordick JS, Tessier PM
Polyphenolic glycosides and aglycones utilize opposing pathways to selectively remodel and inactivate toxic oligomers of amyloid β.
Chembiochem. 2011 Jul 25;12(11):1749-58. PubMed: 21671331PAPER Vicent GP, Nacht AS, Font-Mateu J, Castellano G, Gaveglia L, Ballaré C, Beato M
Four enzymes cooperate to displace histone H1 during the first minute of hormonal gene activation.
Genes Dev. 2011 Apr 15;25(8):845-62. PubMed: 21447625PAPER Miñano-Molina AJ, España J, Martín E, Barneda-Zahonero B, Fadó R, Solé M, Trullás R, Saura CA, Rodríguez-Alvarez J
Soluble oligomers of amyloid-beta peptide disrupt membrane trafficking of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptor contributing to early synapse dysfunction.
J Biol Chem. 2011 Aug 5;286(31):27311-21. PubMed: 21665950PAPER Luchsinger JA, Cheng D, Tang MX, Schupf N, Mayeux R
Central Obesity in the Elderly is Related to Late-onset Alzheimer Disease.
Alzheimer Dis Assoc Disord. 2012 Apr 1;26(2):101-5. PubMed: 21666429PAPER Lahiani-Cohen I, Lourbopoulos A, Haber E, Rozenstein-Tsalkovich L, Abramsky O, Grigoriadis N, Rosenmann H
Moderate environmental enrichment mitigates tauopathy in a neurofibrillary tangle mouse model.
J Neuropathol Exp Neurol. 2011 Jul;70(7):610-21. PubMed: 21666497PAPER Kasuya M, Meguro K, Okamura N, Funaki Y, Ishikawa H, Tanaka N, Iwata R, Yanai K
Greater Responsiveness to Donepezil in Alzheimer Patients With Higher Levels of Acetylcholinesterase Based on Attention Task Scores and a Donepezil PET Study.
Alzheimer Dis Assoc Disord. 2011 Jun 9; PubMed: 21666432Current Filters
No filters selected